Daiichi-Sankyo (South Korea)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi-Sankyo (South Korea), South Korea, covering academic research published from 2002 to 2024. Read More.
Open Access Percentage
74%
Total
Publications
282
Total Open
Publications
208
Total
Citations
7.8K
Open Access
Percentage
74%
Total
Publications
282
Total Open
Publications
208
Total
Citations
7.8K
Breakdown
Publisher Open
47%
Both
15%
Other Platform Open
10%
Closed
28%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 16%
26
Hybrid 15%
26
No Guarantees 69%
115
Other Platform Open
Domain 63%
46
Institution 18%
13
Preprint 15%
11
Other Internet 15%
11
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 46 |
DOI | Other Internet | 11 |
Research Square | Preprint | 10 |
Royal Netherlands Academy of Arts and Sciences | Institution | 4 |
Europe PMC | Domain | 3 |
University of Southern Denmark | Institution | 2 |
Yonsei University | Institution | 1 |
University of Turin | Institution | 1 |
University of Padua | Institution | 1 |
University of Modena and Reggio Emilia | Institution | 1 |